In 2025, the company delivered a solid +11.81% YoY revenue growth, largely driven by its vaccines portfolio: Shingrix ($4.85B) continues to lead with strong global uptake in shingles prevention, Bexsero ($1.61B) is gaining traction amid rising meningitis awareness and immunization programs, while Boostrix ($882.31M) remains a steady contributor in adult and adolescent vaccination, highlighting the strength of GSKs vaccines-led growth strategy
From there click Pharmacy Benefit Information to be directed to the QuartzRx member portal
Hims offers both oral and injectable options, while Peak Wellness is injectable only
Common GLP-1 Treatment Options: An Overview Understanding the different GLP-1 treatment options available can be overwhelming
Use resources like comprehensive diet plans and meal planning guides to fill the gap that MEDVi leaves open
For these reasons, the Pendulum probiotics may be worth discussing with a health care professional as an add-on to an already healthy routine
